Greenlight Capital Re, Ltd.
NASDAQ:GLREInsurance - Reinsurance
-$0.12 today
- Market cap
- $527.77M
- Beta
- 0.33
- P/E (TTM)
- 6.7
- EPS (TTM)
- $2.41
Volume 0.10M
Average 0.21M
GLRE Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Greenlight Capital Re, Ltd.NASDAQ: GLRE
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How GLRE compares with its peers on the latest reported figures
- GLRE's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for GLRE, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
PLGOPelagos Insurance Capital Limit | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GLRE) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for GLRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 570.46M | 477.63M | 632.35M | 647.97M | 696.35M |
| Cost of Revenue | 519.94M | 459.63M | 528.88M | 604.04M | 411.59M |
| Gross Profit | 50.52M | 18M | 103.46M | 43.93M | 284.76M |
| Gross Margin | 8.9% | 3.8% | 16.4% | 6.8% | 40.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 29.37M | 17.79M | 23.65M | 0 | 0 |
| Operating Expenses | 29.2M | (6.53M) | 16.53M | 365K | 206.45M |
| Depreciation & Amortization | 16K | 79K | 0 | 0 | 0 |
| EBITDA | 39.26M | 35.52M | 94.96M | 52.75M | 83.1M |
| EBITDA Margin | 6.9% | 7.4% | 15.0% | 8.1% | 11.9% |
| Operating Income | 21.32M | 24.53M | 86.93M | 43.57M | 78.31M |
| Operating Margin | 3.7% | 5.1% | 13.7% | 6.7% | 11.2% |
| Interest Income | 0 | 4.47M | 35.63M | 32.43M | 0 |
| Interest Expense | 17.92M | 10.92M | 8.03M | 9.18M | 4.79M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 21.32M | 24.53M | 86.93M | 43.57M | 78.31M |
| Pre-Tax Margin | 3.7% | 5.1% | 13.7% | 6.7% | 11.2% |
| Income Tax Expense | 3.75M | (816K) | 100K | 749K | 3.48M |
| Net Income | 17.58M | 25.34M | 86.83M | 42.82M | 74.83M |
| Net Margin | 3.1% | 5.3% | 13.7% | 6.6% | 10.7% |
| EPS (Basic) | 0.51 | 0.75 | 2.55 | 1.26 | 2.21 |
| EPS (Diluted) | 0.51 | 0.64 | 2.50 | 1.24 | 2.17 |
| Weighted Avg Shares | 34.2M | 33.91M | 34.07M | 34.1M | 33.82M |
| Weighted Avg Shares (Diluted) | 34.35M | 39.77M | 34.8M | 34.65M | 34.5M |
Greenlight Capital Re, Ltd.
NASDAQ:GLRE
Intrinsic Alpha fair value
Locked
Current Price
$16.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.